22-30461562-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_174975.5(SEC14L3):c.904G>A(p.Val302Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000141 in 1,614,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_174975.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEC14L3 | NM_174975.5 | c.904G>A | p.Val302Ile | missense_variant | 10/12 | ENST00000215812.9 | NP_777635.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEC14L3 | ENST00000215812.9 | c.904G>A | p.Val302Ile | missense_variant | 10/12 | 1 | NM_174975.5 | ENSP00000215812.5 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152022Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251196Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135764
GnomAD4 exome AF: 0.000132 AC: 193AN: 1461890Hom.: 0 Cov.: 35 AF XY: 0.000132 AC XY: 96AN XY: 727246
GnomAD4 genome AF: 0.000230 AC: 35AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.904G>A (p.V302I) alteration is located in exon 10 (coding exon 10) of the SEC14L3 gene. This alteration results from a G to A substitution at nucleotide position 904, causing the valine (V) at amino acid position 302 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at